Phase II, open-label, multicenter study of treatment with cetuximab and capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer. [Estudio multicéntrico fase II, abierto, de tratamiento con cetuximab y capecitabina en primera línea de tratamiento en pacientes ancianos con un cáncer colorrectal metastático]
Latest Information Update: 14 Apr 2022
At a glance
- Drugs Capecitabine (Primary) ; Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 14 Apr 2022 New trial record